US Stock MarketDetailed Quotes

PRLD Prelude Therapeutics

Watchlist
  • 1.300
  • +0.412+46.40%
Close Dec 20 16:00 ET
  • 1.280
  • -0.020-1.54%
Post 20:01 ET
71.55MMarket Cap-0.73P/E (TTM)

Prelude Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-6.28%-27.3M
16.67%-23.06M
-5.50%-31.79M
-27.87%-107.06M
-2.84%-23.58M
-25.66%-25.68M
-49.82%-27.67M
-37.63%-30.13M
-0.24%-83.73M
10.80%-22.93M
Net income from continuing operations
-5.43%-32.27M
-14.16%-34.74M
-13.40%-31.43M
-5.54%-121.83M
-15.48%-33.08M
-2.17%-30.61M
-11.17%-30.43M
5.93%-27.72M
-3.35%-115.44M
12.79%-28.64M
Depreciation and amortization
45.16%405K
60.85%452K
53.24%426K
-11.71%1.17M
-8.56%331K
-17.21%279K
-11.64%281K
-9.45%278K
44.70%1.32M
24.83%362K
Other non cash items
-13.66%392K
-10.18%397K
-4.17%414K
12.69%1.94M
39.13%608K
3.42%454K
2.55%442K
5.11%432K
29.37%1.72M
9.25%437K
Change In working capital
-0.76%-933K
240.01%6.07M
41.74%-5.21M
-1,224.36%-10.48M
594.94%3.72M
-170.42%-926K
-496.52%-4.33M
-1,132.55%-8.94M
-74.29%932K
-125.53%-751K
-Change in prepaid assets
-97.58%109K
37.83%572K
88.69%-788K
-136.98%-9.11M
-2,699.21%-7.05M
187.35%4.5M
-71.65%415K
-7,589.25%-6.97M
-178.08%-3.84M
-121.91%-252K
-Change in payables and accrued expense
-12.57%1.88M
153.60%2.3M
-231.00%-5.06M
-96.11%252K
5,879.41%3.93M
-68.86%2.15M
-7,773.21%-4.3M
-283.21%-1.53M
1.89%6.49M
93.67%-68K
-Change in other current liabilities
117.28%80K
142.70%193K
245.48%643K
5.08%-1.62M
38.05%-267K
-6.68%-463K
-5.85%-452K
-5.49%-442K
-25.90%-1.71M
-5.64%-431K
Cash from discontinued investing activities
Operating cash flow
-6.28%-27.3M
16.67%-23.06M
-5.50%-31.79M
-27.87%-107.06M
-2.84%-23.58M
-25.66%-25.68M
-49.82%-27.67M
-37.63%-30.13M
-0.24%-83.73M
10.80%-22.93M
Investing cash flow
Cash flow from continuing investing activities
-28.66%10.73M
134.63%26.12M
73.46%31.22M
-142.41%-34.65M
470.92%7.74M
-30.37%15.05M
-539.01%-75.43M
-56.68%18M
130.97%81.69M
175.11%1.36M
Net PPE purchase and sale
89.34%-63K
63.48%-359K
64.32%-289K
-16.36%-3.51M
-187.28%-1.13M
35.48%-591K
-29.68%-983K
14.92%-810K
-29.96%-3.02M
-32.32%-393K
Net investment purchase and sale
-30.95%10.8M
135.57%26.48M
67.53%31.51M
-136.75%-31.13M
407.15%8.87M
-30.58%15.64M
-514.98%-74.44M
-55.74%18.81M
132.40%84.71M
215.99%1.75M
Cash from discontinued investing activities
Investing cash flow
-28.66%10.73M
134.63%26.12M
73.46%31.22M
-142.41%-34.65M
470.92%7.74M
-30.37%15.05M
-539.01%-75.43M
-56.68%18M
130.97%81.69M
175.11%1.36M
Financing cash flow
Cash flow from continuing financing activities
-248.86%-131K
-99.95%59K
94.80%-14K
16,635.58%136.4M
16,181.94%25.24M
-40.54%88K
30,913.65%111.34M
-275.82%-269K
-99.51%815K
-92.07%155K
Net issuance payments of debt
---148K
----
----
----
----
--0
----
----
----
----
Net common stock issuance
--0
----
----
--135.73M
--24.94M
--104K
----
----
--0
--0
Proceeds from stock option exercised by employees
--56K
-26.78%257K
-92.86%2K
-16.44%681K
94.84%302K
--0
-2.23%351K
-81.70%28K
-78.42%815K
-93.13%155K
Net other financing activities
---39K
---102K
94.61%-16K
---17K
---1K
----
----
---297K
----
----
Cash from discontinued financing activities
Financing cash flow
-248.86%-131K
-99.95%59K
94.80%-14K
16,635.58%136.4M
16,181.94%25.24M
-40.54%88K
30,913.65%111.34M
-275.82%-269K
-99.51%815K
-92.07%155K
Net cash flow
Beginning cash position
4.53%31.87M
29.25%28.75M
-15.34%29.34M
-3.41%34.65M
-64.43%19.94M
-44.31%30.49M
-60.05%22.25M
-3.41%34.65M
-83.57%35.87M
-8.72%56.07M
Current changes in cash
-58.24%-16.69M
-62.15%3.12M
95.29%-584K
-334.51%-5.31M
143.87%9.4M
-901.67%-10.55M
988.47%8.25M
-162.63%-12.4M
99.33%-1.22M
16.18%-21.42M
End cash Position
-23.88%15.18M
4.53%31.87M
29.25%28.75M
-15.34%29.34M
-15.34%29.34M
-64.43%19.94M
-44.31%30.49M
-60.05%22.25M
-3.41%34.65M
-3.41%34.65M
Free cash flow
-4.13%-27.36M
18.27%-23.42M
-3.67%-32.08M
-27.47%-110.58M
-5.95%-24.71M
-23.03%-26.27M
-49.02%-28.65M
-35.44%-30.94M
-1.04%-86.75M
10.30%-23.32M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -6.28%-27.3M16.67%-23.06M-5.50%-31.79M-27.87%-107.06M-2.84%-23.58M-25.66%-25.68M-49.82%-27.67M-37.63%-30.13M-0.24%-83.73M10.80%-22.93M
Net income from continuing operations -5.43%-32.27M-14.16%-34.74M-13.40%-31.43M-5.54%-121.83M-15.48%-33.08M-2.17%-30.61M-11.17%-30.43M5.93%-27.72M-3.35%-115.44M12.79%-28.64M
Depreciation and amortization 45.16%405K60.85%452K53.24%426K-11.71%1.17M-8.56%331K-17.21%279K-11.64%281K-9.45%278K44.70%1.32M24.83%362K
Other non cash items -13.66%392K-10.18%397K-4.17%414K12.69%1.94M39.13%608K3.42%454K2.55%442K5.11%432K29.37%1.72M9.25%437K
Change In working capital -0.76%-933K240.01%6.07M41.74%-5.21M-1,224.36%-10.48M594.94%3.72M-170.42%-926K-496.52%-4.33M-1,132.55%-8.94M-74.29%932K-125.53%-751K
-Change in prepaid assets -97.58%109K37.83%572K88.69%-788K-136.98%-9.11M-2,699.21%-7.05M187.35%4.5M-71.65%415K-7,589.25%-6.97M-178.08%-3.84M-121.91%-252K
-Change in payables and accrued expense -12.57%1.88M153.60%2.3M-231.00%-5.06M-96.11%252K5,879.41%3.93M-68.86%2.15M-7,773.21%-4.3M-283.21%-1.53M1.89%6.49M93.67%-68K
-Change in other current liabilities 117.28%80K142.70%193K245.48%643K5.08%-1.62M38.05%-267K-6.68%-463K-5.85%-452K-5.49%-442K-25.90%-1.71M-5.64%-431K
Cash from discontinued investing activities
Operating cash flow -6.28%-27.3M16.67%-23.06M-5.50%-31.79M-27.87%-107.06M-2.84%-23.58M-25.66%-25.68M-49.82%-27.67M-37.63%-30.13M-0.24%-83.73M10.80%-22.93M
Investing cash flow
Cash flow from continuing investing activities -28.66%10.73M134.63%26.12M73.46%31.22M-142.41%-34.65M470.92%7.74M-30.37%15.05M-539.01%-75.43M-56.68%18M130.97%81.69M175.11%1.36M
Net PPE purchase and sale 89.34%-63K63.48%-359K64.32%-289K-16.36%-3.51M-187.28%-1.13M35.48%-591K-29.68%-983K14.92%-810K-29.96%-3.02M-32.32%-393K
Net investment purchase and sale -30.95%10.8M135.57%26.48M67.53%31.51M-136.75%-31.13M407.15%8.87M-30.58%15.64M-514.98%-74.44M-55.74%18.81M132.40%84.71M215.99%1.75M
Cash from discontinued investing activities
Investing cash flow -28.66%10.73M134.63%26.12M73.46%31.22M-142.41%-34.65M470.92%7.74M-30.37%15.05M-539.01%-75.43M-56.68%18M130.97%81.69M175.11%1.36M
Financing cash flow
Cash flow from continuing financing activities -248.86%-131K-99.95%59K94.80%-14K16,635.58%136.4M16,181.94%25.24M-40.54%88K30,913.65%111.34M-275.82%-269K-99.51%815K-92.07%155K
Net issuance payments of debt ---148K------------------0----------------
Net common stock issuance --0----------135.73M--24.94M--104K----------0--0
Proceeds from stock option exercised by employees --56K-26.78%257K-92.86%2K-16.44%681K94.84%302K--0-2.23%351K-81.70%28K-78.42%815K-93.13%155K
Net other financing activities ---39K---102K94.61%-16K---17K---1K-----------297K--------
Cash from discontinued financing activities
Financing cash flow -248.86%-131K-99.95%59K94.80%-14K16,635.58%136.4M16,181.94%25.24M-40.54%88K30,913.65%111.34M-275.82%-269K-99.51%815K-92.07%155K
Net cash flow
Beginning cash position 4.53%31.87M29.25%28.75M-15.34%29.34M-3.41%34.65M-64.43%19.94M-44.31%30.49M-60.05%22.25M-3.41%34.65M-83.57%35.87M-8.72%56.07M
Current changes in cash -58.24%-16.69M-62.15%3.12M95.29%-584K-334.51%-5.31M143.87%9.4M-901.67%-10.55M988.47%8.25M-162.63%-12.4M99.33%-1.22M16.18%-21.42M
End cash Position -23.88%15.18M4.53%31.87M29.25%28.75M-15.34%29.34M-15.34%29.34M-64.43%19.94M-44.31%30.49M-60.05%22.25M-3.41%34.65M-3.41%34.65M
Free cash flow -4.13%-27.36M18.27%-23.42M-3.67%-32.08M-27.47%-110.58M-5.95%-24.71M-23.03%-26.27M-49.02%-28.65M-35.44%-30.94M-1.04%-86.75M10.30%-23.32M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.